Tickwind
HoyOportunidadesMercadosChat con IA
ES
Iniciar sesiónRegistrarse
Tickwind

Lee cada tick. Ve hacia dónde sopla el mercado.

  • XInglés
  • TelegramChino
  • BoletínInglés

Producto

  • Mercados
  • Zonas temáticas
  • Todas las acciones
  • Comparar
  • Acciones en tendencia
  • Oportunidades
  • Noticias
  • Discusión
  • Lista de seguimiento
  • Novedades

Cuenta

  • Ajustes
  • Boletín
  • Para prensa e investigación
  • Servidor MCP
  • Contacto
  • Iniciar sesión
  • Registrarse
MercadosZonas temáticasTodas las accionesCompararAcciones en tendenciaOportunidadesNoticiasDiscusiónLista de seguimientoNovedadesAjustesBoletínPara prensa e investigaciónServidor MCPContactoIniciar sesiónRegistrarse

© 2026 Tickwind. No es asesoría de inversión.

Hecho para el inversor curioso.

Home/LQDA/vs peers

LQDALiquidia Corpvs its industry peers

A metric-by-metric comparison of Liquidia Corp against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.

Full peer comparison
Peers: same SEC industry
EmpresaMarket capP/E (TTM)P/BP/SRevenue growth (YoY)Earnings growth (YoY)EBIT marginROEROICPiotroski F1y total returnDividend yield
LQDALiquidia CorpEsta$3.8B#830.1x#319.4x#1123.9x#51031.2%#147.1%#4-32.5%#5-35.3%#11——67.1%#4—
DNTHDianthus Therapeutics, Inc. /DE/$4.6B#2—4.0x#72274.9x#10-67.3%#9-91.1%#11-8739.3%#10-13.9%#8————
TVTXTravere Therapeutics, Inc.$4.8B#1—210.4x#129.7x#3110.5%#392.1%#1-12.8%#4-113.1%#12——43.3%#5—
GOSSGossamer Bio, Inc.$4.4B#3——91.0x#8-57.7%#8-201.4%#12-352.2%#8———-95.3%#9—
GPCRStructure Therapeutics Inc.$4.4B#4—3.2x#4——-15.2%#7—-10.4%#7——-37.7%#8—
EWTXEdgewise Therapeutics, Inc.$4.1B#5—9.1x#9——-25.4%#8—-0.0%#4-50.9%#6—109.8%#3—
ARQTArcutis Biotherapeutics, Inc.$4.0B#6145.5x#418.2x#1010.7x#491.3%#488.5%#2-3.3%#3-7.3%#5-4.1%#3—29.3%#6—
TNGXTango Therapeutics, Inc.$3.9B#7—3.8x#662.7x#748.3%#522.0%#5-178.4%#6-9.9%#6——189.2%#1—
ABCLAbCellera Biologics Inc.$3.7B#9—4.2x#849.7x#6160.6%#210.1%#6-289.0%#7-16.3%#9-28.0%#4—127.1%#2—
XENE$3.7B#10—3.0x#2493.8x#9—-47.6%#9-4974.3%#9-27.8%#10-32.5%#5———
OGN$3.6B#1117.7x#23.0x#30.6x#1-2.9%#7-78.4%#1014.9%#115.7%#24.9%#25#1—2.4%#1
PBLSParabilis Medicines, Inc.$3.6B#12—3.4x#5————0.0%#3————
ACADACADIA PHARMACEUTICALS INC$3.5B#139.2x#12.7x#13.3x#211.9%#673.0%#39.8%#229.9%#111.4%#1—-8.0%#7—

Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-04.

Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice

LQDA's peers

DNTHTVTXGOSSGPCREWTXARQTTNGXABCLXENEOGNPBLSACAD
← LQDA overview